Dose-levels and first signs of efficacy in contemporary oncology phase 1 clinical trials.
<h4>Purpose</h4>Phase 1 trials play a crucial role in oncology by translating laboratory science into efficient therapies. Molecular targeted agents (MTA) differ from traditional cytotoxics in terms of both efficacy and toxicity profiles. Recent reports suggest that higher doses are not...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Public Library of Science (PLoS)
2011
|
| Subjects: | |
| Online Access: | https://doaj.org/article/5a2a81cdc79344aebd66a927e68dc8c6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|